| PMC Abbreviation | Oncol Innov Ther |
|---|---|
| ISSN Number | XXXX-XXXX |
| Prefix DOI | 10.67375/OncolInnovTher |
| Peer Review | Double-Blind |
| Current Volume | Volume 1 |
| Manuscript Processing | 28–35 Days (After Submission) |
| Publication Model | Open Access |
| Year of Inaugural Volume | 2026 |
| Contact Email | contact@zenithpublications.org |
| Language | English |
Oncology Innovation & Therapeutics is a peer-reviewed, open-access journal committed to advancing research, clinical innovation, and therapeutic development in oncology. The journal offers a global platform for publishing original investigations, systematic reviews, translational studies, biomarker development, clinical trials, and technology-enabled therapeutic strategies that tackle cancer at molecular, cellular, and system levels.
Our mission is to accelerate the translation of cutting-edge cancer science into effective patient-centred therapies, while promoting data-driven innovation, interdisciplinary collaboration, and global access. We invite contributions from oncologists, cancer biologists, translational scientists, biomedical engineers, data scientists, and healthcare system innovators. The journal is dedicated to rigorous peer review, transparent publishing, and wide dissemination to enhance cancer care outcomes worldwide.
Abstract: Introduction: Radiation therapy has evolved substantially in recent years, with Radiation Therapists and Therapeutic radiographers (RTTs) expanding beyond technical roles...
Read Full Article →Abstract: Disulfidptosis represents a recently characterized form of programmed cell death driven by an intracellular imbalance between cystine and the vital reductant...
Read Full Article →